La Vignera S, et al
Leah Liszak, Meghan Etsey, Yun Weisholtz, MD-PhD on behalf of AMWA Gender Equity Task Force Diabetes care has entered an era of precision therapeutics: we no longer treat blood sugar as a single entity but rather tailor regimens to comorbidities, risk profiles, and, critically, individual biology
If confirmed, this could eventually be due to small differences in bioavailability, distribution or elimination of the peptide-antibody fusion compared to conventional mAbs
Large CPG companies like Nestl see this trend as an opportunity to develop new, nutrient-rich, healthier companion GLP-1 products. In May 2024, Nestl launched its first GLP-1 companion brand, Vital Pursuit, which consists of portion-aligned foods high in protein and essential nutrients
Dry them completely